Jade Biosciences, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Jade Biosciences, Inc. (JBIO) had Common Stock, Capital Shares Reserved for Future Issuance of 34.79 million shares as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-10
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 34.79M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 35.36M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 31.94M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 36.49M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 34.79M shares 10-Q · filed 2026-08-10 |
| 2026-03-31 | 35.36M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 31.94M shares 10-Q · filed 2026-08-10 |
| 2025-09-30 | 36.49M shares 10-Q · filed 2025-11-14 |
| 2025-06-30 | 36.49M shares 10-Q · filed 2025-08-13 |
| 2025-03-31 | 6.98M shares 10-Q · filed 2025-04-25 |
| 2024-12-31 | 6.98M shares 10-K · filed 2025-03-27 |
| 2024-09-30 | 7.10M shares 10-Q · filed 2024-11-12 |
| 2024-06-30 | 7.11M shares 10-Q · filed 2024-08-12 |
| 2024-03-31 | 7.27M shares 10-Q · filed 2024-05-13 |
| 2023-12-31 | 6.29M shares 10-K · filed 2024-03-25 |
| 2023-09-30 | 6.40M shares 10-Q · filed 2023-11-13 |
| 2023-06-30 | 6.42M shares 10-Q · filed 2023-08-14 |
| 2023-03-31 | 6.54M shares 10-Q · filed 2023-05-15 |
| 2022-12-31 | 5.43M shares 10-K · filed 2023-03-29 |
| 2022-09-30 | 5.65M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 5.74M shares 10-Q · filed 2022-08-15 |
| 2022-03-31 | 5.75M shares 10-Q · filed 2022-05-16 |
| 2021-12-31 | 4.77M shares 10-K · filed 2022-03-30 |
| 2021-09-30 | 4.77M shares 10-Q · filed 2021-11-15 |
| 2021-06-30 | 18.72M shares 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |